Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Down 0.27%

Collegium Pharmaceutical reported an EPS of $0.20, which was below expectations, resulting in a slight decline in stock price by 0.27%. The lack of revenue figures and management commentary leaves investors with limited insights into the company's performance and future outlook. The market's reaction suggests cautious sentiment among investors following the earnings report.